Home › NDC Lookup › Ingredients › Tolnaftate › 51672-2020-02
Tolnaftate Antifungal 1 g/100g Cream — NDC 51672-2020-02 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Tolnaftate Antifungal 1 g/100g Cream — NDC 51672-2020-2 (Billing 51672-2020-02)

by Sun Pharmaceutical Industries, Inc. · 1 TUBE in 1 CARTON / 30 g in 1 TUBE

This is a package of Tolnaftate Antifungal 1 g/100g Cream from Sun Pharmaceutical Industries, Inc., marketed since Jan 1995 and currently FDA-listed; retail pharmacies pay about $0.1189 per g (NADAC). It is the main listing for this product, which comes in 2 package sizes.

NDC 51672-2020-02
🏷️ FDA NDC (as labeled) 51672-2020-2 billing pads the package segment with a zero
This package
Contains30 g in 1 tube Cost per g$0.1189 NADAC Per package$3.57 / 30 g Pack sizes2 compare ↓
Also priced by: Medicaid pays $0.3021/unit — full pricing hub ↓
Main listing for product 51672-2020 · Also comes in: 15 g 51672-2020-1
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 8, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

NDC database record

One package, one record: these facts belong to NDC 51672-2020-2 alone.

Record
FDA NDC Directory package listing · Human OTC drug
Code segments
51672 labeler · 2020 product · 2 package
Package marketed since
Jan 1, 1995
Sample package
No — commercial package
Listing certified through
Dec 31, 2026
Barcode (UPC-A, from the NDC)
3 5167220202 6
Medicaid fills, this package
2,848 prescriptions in the last four reported quarters
FDA record last changed
Jul 24, 2026

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 51672-2020-2
Product NDC 51672-2020
11-digit billing NDC 51672202002
NCPDP billing unit GM — per gram (weight)
RxCUI 103951
UNII 06KB629TKV
Application # M005
SPL Set ID fa16fa08-fbbd-4f45-b64a-9bffe78e8861
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 1995-01-01
Route TOPICAL
Dosage form CREAM
Substance TOLNAFTATE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 90150085003705
GPI class Tolnaftate
GCN Seq No 007339
GCN 30300
HICL code 003186
Ingredient (HICL) Tolnaftate
HIC1 code Q
Therapeutic class — broad (HIC1) Ear/Eye/Nose/Rectum/Topical/Vagina/Other
HIC2 code Q5
Therapeutic class — intermediate (HIC2) Agents Acting Principally On The Skin
HIC3 code Q5F
Therapeutic class — specific (HIC3) Topical Antifungals
AHFS code 84:04.08.40
AHFS class Thiocarbamates(Skin And Mucous Membrane)
FDB label name TOLNAFTATE 1% CREAM
FDB brand name Tolnaftate
Legend status O — Over-the-counter (OTC) drug or device
Quick answers
  • GSN (GCN sequence number): 007339
  • GCN: 30300
  • GPI-14 (Medi-Span): 90150085003705
  • HICL (First Databank): 003186
  • AHFS class code: 84:04.08.40
  • RxCUI (RxNorm): 103951
Why two NDCs? The FDA registers this code as 51672-2020-2 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 51672-2020-02. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other antifungals for topical use class.

Drug family (ATC) Other antifungals for topical use
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

Label name TOLNAFTATE 1% CREAM Ingredient Tolnaftate
📗 Our plain-language guide HelloPharmacist
  • It treats fungal skin infections like athlete's foot, ringworm and, in some products, jock itch. Many products also help prevent athlete's foot. Some are made for skin around the n...
  • Wash and dry the area well, then apply a thin layer. Most products are used twice a day, morning and night. The length of use varies, often 4 weeks for athlete's foot and ringworm,...
  • The main one is skin irritation. If that happens, stop using it and talk to a doctor.
  • Call if you see no improvement within 4 weeks for athlete's foot or ringworm, or 2 weeks for jock itch. Call if irritation develops. Call right away if anyone swallows it.
📖 Read our full Tolnaftate guide →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly $0.119 $3.57 / 30 g
Medicaid paysCMS SDUD · 12 mo $0.3021 $9.06 / 30 g
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
NADAC price history (per g) — tap or hover for the price & month
Jan 2022 Aug 2022 Jan 2026 Sep 2026 $0.137 $0.105
▼ Down 6% over the last 24 months.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Per unit Per pack Marketing startMarketing endStatus
51672-2020-01 51672-2020-1 1 TUBE in 1 CARTON / 15 g in 1 TUBE $0.1500 / g $2.25 1995-01-01 — Active
51672-2020-02 You're viewing this Main listing 1 TUBE in 1 CARTON / 30 g in 1 TUBE $0.1189 / g $3.57 1995-01-01 — Active

This pack has the lowest per-g cost of the 2 priced pack sizes ($0.1189 NADAC).

In Medicaid, this is the most-dispensed pack of this product — about 74% of fills over the last four reported quarters. See all packs ↓

Pack size FAQ

What quantity is in this package?
This package is listed by the FDA — 1 tube in 1 carton / 30 g in 1 tube.
What NDC number is used to bill for this package of Tolnaftate Antifungal 1 g/100g Cream?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Prices are the latest CMS NADAC pharmacy acquisition cost per NDC; per-pack figures are per-unit × pack quantity, shown only when the pack is denominated in the same measure NADAC prices.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
CR-371059 Tolnaftate 1% Cream 1 g/100g 00536-1315-43 Rugby 1 g $0.090 — Availability likely save 24%
Tolnaftate Antifungal 10 mg/g 24385-0032-03 Amerisource 1 tube $0.119 — Availability likely —
Tolnaftate Antifungal 1 g/100gthis 51672-2020-02 Sun 1 tube $0.119 — Availability likely —
Tolnaftate Cream 1% ANTIFUNGAL 1 g/100g 70000-0084-01 CARDINAL 1 tube $0.119 — Availability likely —
sunmark antifungal 10 mg/g 49348-0155-29 Strategic 1 tube $0.150 — Availability likely +26%
Tolnaftate Antifungal 1 g/100g 70677-1001-01 STRATEGIC 1 tube $0.150 — Availability likely +26%
Odor-Eaters Athletes Foot 1 g/100g 10157-3100-01 Blistex 1 tube — — FDA listed —
Mentholatum Heel Revival Cream 10 mg/g 10742-0020-01 The 1 tube — — FDA listed —
Tinactin 10 mg/g 11523-0934-02 Bayer 1 tube — — FDA listed —
Tinactin 10 mg/g 11523-1190-01 Bayer 1 tube — — FDA listed —
Tolnaftate 10 mg/g 11527-0051-40 Sheffield 1 tube — — FDA listed —
Signature Care Antifungal Cream Tolnaftate 1% 10 mg/g 21130-0887-14 BETTER 1 tube — — FDA listed —
meijer antifungal 10 mg/g 41250-0499-01 Meijer 1 tube — — FDA listed —
AVON HeXashield Athletes Foot Cream 10 mg/g 43136-0104-01 Tai 1 tube — — FDA listed —
CLARUS Antifungal 1 g/100g 44577-0001-01 Clinical 45 g — — FDA listed —
CLARUS Antifungal 10 mg/g 44577-0470-00 Clinical 1 tube — — FDA listed —
equate Athletes Foot 10 mg/g 49035-0499-03 Wal-Mart 1 tube — — FDA listed —
sunmark antifungal 10 mg/g 50090-3358-00 A-S 1 tube — — FDA listed —
CR-371059 Tolnaftate 1% 1 g/100g 50090-6147-00 A-S 14.8 g — — FDA listed —
CAREALL Tolnaftate 10 mg/g 51824-0001-01 New 28 g — — FDA listed —
Family Wellness Athletes Foot Tolnaftate 1 Cream 10 mg/g 55319-0991-00 Family 1 tube — — FDA listed —
Athletes Foot Antifungal .01 mg/10g 55910-0341-24 Dollar 1 tube — — FDA listed —
Pedikleer 1 g/100g 57237-0354-15 Rising 1 tube — — FDA listed —
Hongo Killer 10 mg/g 58593-0286-01 Efficient 1 tube — — FDA listed —
Family Care Antifungal 10 mg/g 65923-0021-28 United 1 tube — — FDA listed —
Winco Antifungal 10 mg/g 67091-0051-28 WinCo 1 tube — — FDA listed —
Winco Foods Tolnaftate 10 mg/g 67091-0276-28 Winco 1 tube — — FDA listed —
Natureplex Tolnaftate Antifungal 10 mg/g 67234-0032-01 Natureplex, 1 tube — — FDA listed —
Tolnaftate Cream 1% 10 mg/g 68016-0152-01 Pharmacy 1 tube — — FDA listed —
Tolnaftate 10 mg/g 68071-4245-05 NuCare 14.18 g — — FDA listed —
Skinheal Antifungal 1 g/100g 69070-0305-01 Zhejiang 1 tube — — FDA listed —
Tolnaftate Cream 1% ANTIFUNGAL 1 g/100g 69396-0016-05 Trifecta 1 tube — — FDA listed —
Tolnaftate Cream 1% ANTIFUNGAL 1 g/100g 69396-0042-05 Trifecta 1 tube — — FDA listed —
Tolnaftate 1 g/100g 69396-0130-01 Trifecta 1 tube — — FDA listed —
Canespies 1 g/100g 69729-0610-05 OPMX 1 tube — — FDA listed —
CVS Health Athletes Foot 10 mg/g 69842-0336-14 CVS 1 tube — — FDA listed —
Athletes Foot 10 mg/g 70084-0510-01 Quantum, 1 tube — — FDA listed —
Aftate Athlete Foot Cream 1 g/100g 70356-0001-01 Sabel 28 g — — FDA listed —
TheraCare Antifungal Cream 10 mg/g 71101-0017-01 Veridian 1 tube — — FDA listed —
Funginix Af 1 g/100g 71229-0103-11 The 28 g — — FDA listed —
Funginix Jock Itch Treatment 1 g/100g 71229-0104-11 The 28 g — — FDA listed —
TriTolnacide C 1 g/100mL 73352-0561-10 Trifluent 1 bottle — — FDA listed —
Dr.Scholl s Odor X Athlete s Foot 10 mg/g 73469-0618-01 Scholl's 1 bottle — — FDA listed —
Thera plus Antifungal Tolnaftate 10 mg/g 80684-0040-01 FOURSTAR 1 tube — — FDA listed —
Derman antifungal cream 10 mg/g 81929-0004-01 Taisho 1 tube — — FDA listed —
Up and Up Antifungal 10 mg/g 82442-0020-28 Target 1 tube — — FDA listed —
Antifungal 1 g/100g 83324-0049-01 Chain 1 tube — — FDA listed —
Sylvirene Fungal Nail Renewal 1 g/100mL 85248-0068-01 Jiangxi 30 ml — — FDA listed —
Tagrid Athletes Foot Treament 10 mg/g 85384-0008-01 TAGRID 100 g — — FDA listed —
Initial Drug Listing - Hermon Athletes Foot 1% Tolnaftate Cream .6 g/60g 85398-0017-01 Beautivity 60 g — — FDA listed —
Hi Vetic 1 g/100g 49873-0056-01 Sato 1 tube — — FDA listed —
Antifungal Medicated Body Wash 1 g/100g 83004-0012-01 Rida 56 g — — FDA listed —
Inlifay ANTIFUNGAL 1 g/100g 83566-0609-01 Guangdong 232 g — — FDA listed —
Phytozine Ringworm Treatment Maximum Strength 1 g/100g 71229-0101-11 The 28 g — — FDA listed —
Rapid MicroGel 1 g/100g 49406-0005-28 The 28 g — — FDA listed —
Terramed Just Think Comfort Armor Antifungal Medicated 1 g/100g 83004-0017-01 Rida 120 g — — FDA listed —
Terramed Just Think Comfort Armor Antifungal Body Wash Tea Tree 1 g/100g 83004-0032-01 Rida 56 g — — FDA listed —
Dryello Dual Action Relief for Athlete Foot 1 g/100g 85565-0002-01 ProPedix, 2 applicators — — FDA listed —
Kdman 1 g/100g 87723-6625-01 Dongguan 200 g — — FDA listed —
Quali Life ANTIFUNGAL PERSIMMON 1 g/100g 83566-0606-01 Guangdong 300 g — — FDA listed —
Quali Life ANTIFUNGAL TEA TREE 1 g/100g 83566-0611-01 Guangdong 300 g — — FDA listed —
Athlete Foot Medicated bar 1 g/100g 85398-0007-01 Beautivity 232 g — — FDA listed —
Hermon Antifungal Bar 1 g/100g 85261-0601-01 Haikou 232 g — — FDA listed —
Dryello Tolnaftate 1% Antifungal 1 g/100g 85565-0005-01 ProPedix, 2 applicators — — FDA listed —
Fungi Nail Toe and Foot 1 g/100g 55505-0185-50 Kramer 1 tube — — FDA listed —
Defense Antifungal Medicated Bar 1 g/100g 70856-3581-02 Defense 1 not — — FDA listed —
Quali Life ANTIFUNGAL CHARCOAL 1 g/100g 83566-0607-01 Guangdong 300 g — — FDA listed —
Kerasal for Athletes Foot Silky Clear 1 g/100g 16864-0100-01 Advantice 1 tube — — Discontinued —
Inlifay ANTIFUNGAL 1 g/100g 60771-0040-01 Guangzhou 232 g — — FDA listed —
Tea Tree Oil Antifungal 1 g/100g 85593-0105-01 Guangzhou 100 g — — FDA listed —
Activ-Charcoal Antifungal 1 g/100g 87800-0002-01 HONG 100 g — — FDA listed —
OAKDOLCHE Tea Tree Oil Antifungal 1 g/100g 87864-0001-01 Nanjing 400 g — — FDA listed —
Dryello Tolnaftate 1% Antifungal 1 g/100g 85565-0008-01 ProPedix, 2 applicators — — FDA listed —
VXGXO antifungal with tea tree oil 1 g/100g 83566-0620-01 Guangdong 200 g — — FDA listed —
BlissCare tea tree oil antifungal 1 g/100g 83566-0619-01 Guangdong 115 g — — FDA listed —
Tolnaftate 1% Antifungal Soaps 1 g/100g 85158-0002-01 Shenzhen 2 pouches — — Discontinued —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
1995
On the market since
Jan 1995
📍
2026
Currently FDA-listed
31 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

🧪 Avoiding an ingredient? See Tolnaftate inactive ingredients by manufacturer: every current product's list side by side, so you can ask your pharmacy for the version that does not list it.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 1P9D0Z171K
    BHT is a synthetic antioxidant that prevents fats and oils in medicines from breaking down and becoming rancid. It helps keep the product stable and effective during storage.
  • UNII 4T6H12BN9U
    Petrolatum is a purified mineral oil-based jelly derived from petroleum. In medicines, it acts as an emollient, lubricant, and moisture barrier to soften skin, reduce friction, and help prevent water loss from formulations.
  • UNII G2M7P15E5P
    Polyethylene glycol 3350 is a synthetic polymer used as a solvent, humectant, and thickening agent in medicines. It helps dissolve other ingredients, retain moisture in the product, and achieve the desired consistency.
  • UNII B697894SGQ
    Polyethylene glycol 400 is a clear, thick liquid made from petroleum-derived polymers. It acts as a solvent and humectant in medicines, helping dissolve active ingredients and retain moisture in the formulation.
  • UNII 15FIX9V2JP
    Titanium dioxide is a bright white mineral powder commonly used as a colorant and opacifying agent. It makes pills and tablets white or lighter in color and helps make coatings non-transparent.

5 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesBHT, PEG-400, PEG-3350, titanium dioxide, white petrolatum

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMed — ingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSun Pharmaceutical Industries, Inc.
FDA applicationM005 (OTC MONOGRAPH DRUG)
Labeler code51672
First marketedJan 1995
Product typeHuman Otc Drug
Portfolio891 products on file

More NDCs from Sun Pharmaceutical Industries, Inc. labeler code 51672

The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 📦 Storage and Handling 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Do Not Use 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 📄 Keep Out of Reach of Children 📄 Questions or Comments 📄 Package Label / Principal Display Panel
🎯 Indications and Usage 33 words ▾

Uses proven clinically effective in the treatment of most athlete's foot (tinea pedis) and ringworm (tinea corporis) helps prevent most athlete's foot with daily use for effective relief of itching, burning and cracking

⏱️ Dosage and Administration 85 words ▾

Directions wash affected area and dry thoroughly apply a thin layer over affected area twice daily (morning and night) supervise children in the use of this product for athlete's foot: pay special attention to spaces between the toes; wear well-fitting, ventilated shoes and change shoes and socks at least once daily use daily for 4 weeks; if condition persists longer, ask a doctor to prevent athlete's foot, apply once or twice daily (morning and/or night) this product is not effective on the scalp or nails

⚠️ Warnings 67 words ▾

Warnings For external use only When using this product avoid contact with eyes Stop use and ask a doctor if irritation occurs there is no improvement within 4 weeks Do not use on children under 2 years of age except under the advice and supervision of a doctor. Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📦 Storage and Handling 21 words ▾

Other information store between 20° to 25°C (68° to 77°F) see carton or tube crimp for lot number and expiration date

🧪 Active Ingredient 4 words ▾

Active ingredient Tolnaftate 1%

🧪 Inactive Ingredients 9 words ▾

Inactive ingredients BHT, PEG-400, PEG-3350, titanium dioxide, white petrolatum

🎯 Purpose 2 words ▾

Purpose Antifungal

📄 Do Not Use 19 words ▾

Do not use on children under 2 years of age except under the advice and supervision of a doctor.

📄 When Using This Product 8 words ▾

When using this product avoid contact with eyes

📄 Stop Use and Ask a Doctor If 16 words ▾

Stop use and ask a doctor if irritation occurs there is no improvement within 4 weeks

📄 Keep Out of Reach of Children 19 words ▾

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

📄 Questions or Comments 3 words ▾

Questions? Call 1-866-923-4914

📄 Package Label / Principal Display Panel 34 words ▾

PRINCIPAL DISPLAY PANEL - 30 g Tube Carton Cures & Prevents Most Athlete's Foot Antifungal Cream Tolnaftate Cream 1% Antifungal NET WT 1 oz (30 g) Principal Display Panel - 30 g Tube Carton

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

Medicaid utilization & spend

📍 This exact package only: Medicaid data is reported per full 11-digit NDC — labeler, product and pack size — so every number here is for this package alone, not the drug overall. Other pack sizes report separately.
💊 Pharmacy benefit only: These are Medicaid outpatient pharmacy claims, billed by NDC. They exclude the medical benefit — clinic- or hospital-administered drugs billed under HCPCS J-codes — so drugs used mostly that way (e.g. Avastin, Lucentis, Keytruda) can look low or missing here. That’s expected, not an error.
📅 Q1 2025 – Q1 2026 · 5 quarters of data
ⓘ The newest quarter is usually incomplete when first published; states restate recent quarters in later CMS releases, so the latest figures typically revise upward. State coverage-policy changes can also shift quarter-to-quarter totals.
Prescriptions last 4 qtrs
2.8K
Units reimbursed last 4 qtrs
98.1K
Gross reimbursed last 4 qtrs
$29.6K
Avg / prescription
$10.40
Avg / unit
$0.3021
Latest quarter Q1 2026
573Rx
Medicaid pays / g
$0.3021
gross reimbursed
vs
NADAC / g
$0.1189
acquisition cost
=
Spread
+$0.1832
+154% vs cost
What Medicaid paid per g (before rebates; includes the pharmacy’s dispensing fee) compared with NADAC — the average price pharmacies pay to buy the drug. A positive spread means Medicaid reimbursed more than the purchase price, before manufacturer rebates.
Fee-for-service vs managed care ⓘ
61% FFS 39% MCO
Fee-for-service · 1,736 Rx Managed care · 1,112 Rx
State Medicaid map
Alaska: no data reported AK Maine: no data reported ME Washington: 4,665 units · 59.7 per 100k residents WA Idaho: no data reported ID Montana: no data reported MT North Dakota: no data reported ND Minnesota: 2,130 units · 37.1 per 100k residents MN Wisconsin: 1,320 units · 22.3 per 100k residents WI Michigan: 9,699 units · 96.6 per 100k residents MI New York: 17,038 units · 87.1 per 100k residents NY Vermont: no data reported VT New Hampshire: no data reported NH Oregon: 930 units · 22.0 per 100k residents OR Nevada: no data reported NV Wyoming: no data reported WY South Dakota: no data reported SD Iowa: no data reported IA Illinois: no data reported IL Indiana: 862 units · 12.6 per 100k residents IN Ohio: 3,742 units · 31.8 per 100k residents OH Pennsylvania: 4,484 units · 34.6 per 100k residents PA New Jersey: 1,509 units · 16.2 per 100k residents NJ Massachusetts: 3,045 units · 43.5 per 100k residents MA California: 34,008 units · 87.3 per 100k residents CA Utah: no data reported UT Colorado: no data reported CO Nebraska: no data reported NE Missouri: 2,250 units · 36.3 per 100k residents MO Kentucky: 3,986 units · 88.1 per 100k residents KY West Virginia: no data reported WV Virginia: no data reported VA Maryland: no data reported MD Connecticut: no data reported CT Rhode Island: no data reported RI Arizona: 600 units · 8.1 per 100k residents AZ New Mexico: no data reported NM Kansas: no data reported KS Arkansas: no data reported AR Tennessee: no data reported TN North Carolina: no data reported NC South Carolina: no data reported SC Delaware: no data reported DE Oklahoma: no data reported OK Louisiana: no data reported LA Mississippi: no data reported MS Alabama: no data reported AL Georgia: no data reported GA D.C.: no data reported DC Hawaii: no data reported HI Texas: 7,796 units · 25.6 per 100k residents TX Florida: no data reported FL
Units reimbursed · per 100k residents
8.196.6
gray = no data reported ⓘ
Colors are per 100,000 residents, so big states don’t automatically dominate. Tap or hover a state for its actual totals.
Tap or hover a state
…for its Medicaid breakdown
🏆 Top states by units · per 100k residents
1 Michigan 96.6 /100k
2 Kentucky 88.1 /100k
3 California 87.3 /100k
4 New York 87.1 /100k
5 Washington 59.7 /100k
6 Massachusetts 43.5 /100k
7 Minnesota 37.1 /100k
8 Missouri 36.3 /100k
National units — by quarter
💵 About the dollar figures: “reimbursed” is what Medicaid paid pharmacies before confidential manufacturer rebates, so the program’s real net cost is lower than these numbers. Fee-for-service and managed-care claims are combined unless split above. Source: CMS State Drug Utilization Data; per-100k rates use 2023 Census population estimates.

Medicaid utilization by pack size

Medicaid (SDUD) totals over the four most recent reported quarters for every package size of this drug — handy when a specific package (e.g. a starter/titration pack) carries little or no Medicaid volume on its own.
1 tube this page51672-2020-02 2,848 Rx · $29,621
1 tube51672-2020-01 1,025 Rx · $10,567
Drug total (last 4 qtrs): 3,873 Rx · 120,993 units · $40,188 gross reimbursed
Tap a pack size to open its page. Source: CMS State Drug Utilization Data, last 4 quarters.

Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for Tolnaftate — the ingredient across all brands.

Top reported reactions

Pain94
Fatigue88
Nausea86
Dyspnoea81
Diarrhoea73
Anxiety69
Headache57

Reporter sex

1,403 reports

Serious outcomes

Death119
Life-threatening60
Reports over time (by year) — tap or hover for the count & year
2019 2021 2023 2026 108 0
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.
← 51672-2018-02 · Sun 51672-2027-01 · Sun →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.